Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.

Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, Moulin M, Bosenberg M, Graversen JH, Auphan-Anezin N, Moestrup SK, Lawrence T.

J Exp Med. 2019 Aug 2. pii: jem.20182124. doi: 10.1084/jem.20182124. [Epub ahead of print]

PMID:
31375534
2.

A Real-Time Cytotoxicity Assay as an Alternative to the Standard Chromium-51 Release Assay for Measurement of Human NK and T Cell Cytotoxic Activity.

Fassy J, Tsalkitzi K, Goncalves-Maia M, Braud VM.

Curr Protoc Immunol. 2017 Aug 1;118:7.42.1-7.42.12. doi: 10.1002/cpim.28.

PMID:
28762488
3.

A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.

Fassy J, Tsalkitzi K, Salavagione E, Hamouda-Tekaya N, Braud VM.

Immunology. 2017 Apr;150(4):489-494. doi: 10.1111/imm.12702. Epub 2017 Jan 19.

Supplemental Content

Loading ...
Support Center